Key Insights

Highlights

Treatment Research

1 treatments under study, led by Lung Cancer Screening With Low Dose Ct Scan

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Not Yet Recruiting1

Clinical Trials (1)

Research Network

Common Treatments

  • Lung Cancer Screening With Low Dose Ct Scan1

Active Sponsors

  • Sociedad Española de Neumología y Cirugía Torácica1
  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1

Top Investigators

Related Conditions

  • Lung Cancer1

Activity Timeline